|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Esophageal Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Esophageal Diseases | |||||
| Esophageal Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Head and Neck Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| 4 | Interventions listed in this trial | ||||
| laparoscopic surgery | |||||
| thoracoscopic surgery | |||||
| 5 | Sponsors listed in this trial | ||||
| Eastern Cooperative Oncology Group | |||||
| National Cancer Institute (NCI) | |||||
| Cancer and Leukemia Group B | |||||